Skip to main content

Published locations for Phase 3 trial supports topical JAK inhibitor for AD in young children

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 3 trial supports topical JAK inhibitor for AD in young children

User login

  • Reset your password
  • /content/phase-3-trial-supports-topical-jak-inhibitor-ad-young-children
  • /edermatologynews/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad
  • /familypracticenews/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad
  • /pediatricnews/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad-young
  • /pediatrics/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad-young
  • /dermatology/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad-young
  • /familymedicine/article/266259/atopic-dermatitis/phase-3-trial-supports-topical-jak-inhibitor-ad